Abstract:Aim: To explore the mechanisms underlying the protection by SO 2 preconditioning against rat myocardial ischemia/reperfusion (I/R) injury. Methods: Male Wistar rats underwent 30-min left coronary artery ligation followed by 120-min reperfusion. An SO 2 donor (1 μmol/kg) was intravenously injected 10 min before the ischemia, while LY294002 (0.3 mg/kg) was intravenously injected 30 min before the ischemia. Plasma activities of LDH and CK were measured with an automatic enzyme analyzer. Myocardial infarct size was detected using Evans-TTC method. The activities of caspase-3 and -9 in myocardium were assayed using a commercial kit, and the levels of p-Akt, Akt, PI3K and p-PI3K were examined with Western blotting. Results: Pretreatment with SO 2 significantly reduced the myocardial infarct size and plasma LDH and CK activities, as well as myocardial caspase-3 and -9 activities in the rats. Furthermore, the pretreatment significantly increased the expression levels of myocardial p-Akt and p-PI3K p85. Administration of the PI3K inhibitor LY294002 blocked all the effects induced by SO 2 pretreatment. Conclusion: The results suggest that the PI3K/Akt pathway mediates the protective effects of SO 2 preconditioning against myocardial I/R injury in rats.

The PI3K/Akt Pathway Mediates the Protection of SO2 Preconditioning Against Myocardial Ischemia/reperfusion Injury in Rats